← Back to headlines
Soleno Therapeutics Investors Offered Opportunity to Lead Securities Fraud Lawsuit
Investors in Soleno Therapeutics, Inc. (SLNO) are being offered an opportunity to lead a securities fraud class action lawsuit against the company.
25 Mar, 21:09 — 25 Mar, 21:09
Related Stories
The OLB Group Reports Q2 Financials; FinVolution Group to Announce Results
41m ago
Mark Cuban and Tech Founders Oppose California Wealth Tax Proposal
3h ago
Greece to Save €2 Billion by Early Debt Repayment in 2026
4h ago
SEC Proposal Would Allow Companies to Announce Earnings Quarterly, Ditch Filings
4h ago